Follow the Poolbeg Pharma plc stock price and the full directors' dealings record of the company, a publicly traded company based in United Kingdom. Shares are listed on the UK market, under the oversight of RNS (LSE). Market capitalisation: €68.7m. The latest transaction was filed on 25 June 2025 (Purchase). Among the most active insiders: Cathal Friel. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
Poolbeg Pharma plc 是一家生物制药公司,专注于开发传染病治疗方法。它利用药物发现平台来识别和开发治疗候选药物。